Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenon versus sevoflurane for depth of hypnosis monitoring during general anesthesia
2008-004132-20Phase 4Active
- Sponsor
- Air Liquide
- Start
- Sep 2008
- Modality
- Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4 trial of xenon and sevoflurane (2 arms), sponsored by Air Liquide. Primary endpoint: Average depth of hypnosis by BIS and cAAI. Started Sep 2008; status: active.
02
Drugs
xenonsevoflurane
Beyond the preview
Go deeper on 2008-004132-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004132-20.